Lv41
470 积分 2021-02-15 加入
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
2小时前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
26天前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
1个月前
已完结
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
1个月前
已完结
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
1个月前
已完结
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
2个月前
已完结
Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium
2个月前
已完结
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
3个月前
已完结
B-cell non-Hodgkin lymphomas
4个月前
已完结
Drug delivery to the central nervous system
4个月前
已完结
皖公网安备34019202002308
